Keith A. Ching

15.2k total citations · 4 hit papers
45 papers, 8.8k citations indexed

About

Keith A. Ching is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Keith A. Ching has authored 45 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Keith A. Ching's work include Renal cell carcinoma treatment (8 papers), Ferroptosis and cancer prognosis (5 papers) and Renal and related cancers (5 papers). Keith A. Ching is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Ferroptosis and cancer prognosis (5 papers) and Renal and related cancers (5 papers). Keith A. Ching collaborates with scholars based in United States, France and United Kingdom. Keith A. Ching's co-authors include M. Cooke, Andrew I. Su, Tim Wiltshire, John R. Walker, John B. Hogenesch, Bing Ren, Roland D. Green, Serge Batalov, Hilmar Lapp and David E. Block and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Keith A. Ching

44 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A gene atlas of the mouse and human protein-encoding transcriptomes

2004 2.8k citations Andrew I. Su, Tim Wiltshire et al. Proceedings of the National Academy of Sciences profile →
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome

2007 2.5k citations Nathaniel D. Heintzman, Rhona Stuart et al. Nature Genetics profile →
Large-scale analysis of the human and mouse transcriptomes

2002 1.2k citations Andrew I. Su, M. Cooke et al. Proceedings of the National Academy of Sciences profile →
Analysis of the Vertebrate Insulator Protein CTCF-Binding Sites in the Human Genome

2007 811 citations Keith A. Ching, Roland D. Green et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith A. Ching United States	24	6.6k	1.4k	1000	989	894	45	8.8k
Mitsuyoshi Nakao Japan	57	7.4k 1.1×	2.3k 1.7×	955 1.0×	1.1k 1.1×	1.0k 1.2×	174	9.6k
Frank C. P. Holstege Netherlands	54	8.9k 1.3×	1.1k 0.8×	801 0.8×	835 0.8×	918 1.0×	156	11.1k
Serge Batalov United States	33	6.1k 0.9×	1.6k 1.1×	1.3k 1.3×	1.2k 1.2×	714 0.8×	49	9.2k
Edgar Wingender Germany	38	6.8k 1.0×	1.3k 0.9×	999 1.0×	919 0.9×	947 1.1×	146	8.9k
Yujiang Geno Shi United States	43	11.1k 1.7×	1.8k 1.3×	735 0.7×	1.9k 2.0×	966 1.1×	73	12.4k
Mitchell Stark Australia	27	5.1k 0.8×	754 0.6×	716 0.7×	1.3k 1.3×	1.2k 1.3×	65	7.5k
Ernest Fraenkel United States	41	7.6k 1.1×	1.2k 0.9×	900 0.9×	573 0.6×	589 0.7×	92	9.7k
Daniel E. Bauer United States	44	7.3k 1.1×	1.4k 1.0×	560 0.6×	2.0k 2.1×	890 1.0×	108	9.4k
Lihua Julie Zhu United States	54	6.8k 1.0×	1.2k 0.9×	656 0.7×	1.2k 1.3×	790 0.9×	165	9.3k
Or Gozani United States	57	9.6k 1.4×	798 0.6×	933 0.9×	839 0.8×	1.2k 1.3×	108	11.7k

Countries citing papers authored by Keith A. Ching

Since Specialization

Citations

This map shows the geographic impact of Keith A. Ching's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith A. Ching with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith A. Ching more than expected).

Fields of papers citing papers by Keith A. Ching

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith A. Ching. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith A. Ching. The network helps show where Keith A. Ching may publish in the future.

Co-authorship network of co-authors of Keith A. Ching

This figure shows the co-authorship network connecting the top 25 collaborators of Keith A. Ching. A scholar is included among the top collaborators of Keith A. Ching based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith A. Ching. Keith A. Ching is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sekeres, Mikkael A., Michael Schuster, Magalie Joris, et al.. (2022). A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes. Annals of Hematology. 101(8). 1689–1701. 11 indexed citations

Motzer, Robert J., Jean‐François Martini, Xinmeng Jasmine Mu, et al.. (2022). Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial. Nature Communications. 13(1). 5959–5959. 7 indexed citations

Powles, Thomas, Srikala S. Sridhar, Yohann Loriot, et al.. (2021). Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial. Nature Medicine. 27(12). 2200–2211. 74 indexed citations

Choueiri, Toni K., James Larkin, Sumanta K. Pal, et al.. (2021). Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial. ESMO Open. 6(3). 100101–100101. 34 indexed citations

Gopal, Ajay K., Ronald Levy, Roch Houot, et al.. (2020). First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas. Clinical Cancer Research. 26(11). 2524–2534. 45 indexed citations

Powles, Thomas, Yohann Loriot, Joaquim Bellmunt, et al.. (2020). 699O Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC): Association between clinical outcomes and exploratory biomarkers. Annals of Oncology. 31. S552–S553. 14 indexed citations

Metz, Patrick J, Keith A. Ching, Tao Xie, et al.. (2020). Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling. Cell Reports. 30(6). 1935–1950.e8. 28 indexed citations

Albigès, Laurence, Brian I. Rini, John B.A.G. Haanen, et al.. (2019). Primary renal tumour shrinkage in patients (pts) who did not undergo upfront cytoreductive nephrectomy (uCN): Subgroup analysis from the phase III JAVELIN Renal 101 trial of first-line avelumab + axitinib (A + Ax) vs sunitinib (S) for advanced renal cell carcinoma (aRCC). Annals of Oncology. 30. v359–v360. 16 indexed citations

Wang, Kai, Qin Zhang, Danan Li, et al.. (2015). PEST Domain Mutations in Notch Receptors Comprise an Oncogenic Driver Segment in Triple-Negative Breast Cancer Sensitive to a γ-Secretase Inhibitor. Clinical Cancer Research. 21(6). 1487–1496. 122 indexed citations

10.

Fernandez-Banet, Julio, Nikki P. Lee, Kin Chan, et al.. (2014). Decoding complex patterns of genomic rearrangement in hepatocellular carcinoma. Genomics. 103(2-3). 189–203. 44 indexed citations

11.

Pavlı́c̀ek, Adam, Maruja E. Lira, Nathan V. Lee, et al.. (2013). Molecular Predictors of Sensitivity to the Insulin-like Growth Factor 1 Receptor Inhibitor Figitumumab (CP-751,871). Molecular Cancer Therapeutics. 12(12). 2929–2939. 31 indexed citations

12.

Hook, Kenneth E., Maruja E. Lira, Keith A. Ching, et al.. (2012). An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735. Molecular Cancer Therapeutics. 11(3). 710–719. 77 indexed citations

13.

Ching, Keith A., Julie L.C. Kan, Hwang-Phill Kim, et al.. (2011). Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer. Molecular Cancer Therapeutics. 11(2). 439–451. 58 indexed citations

14.

Hawkins, R. David, Gary C. Hon, Chuhu Yang, et al.. (2011). Dynamic chromatin states in human ES cells reveal potential regulatory sequences and genes involved in pluripotency. Cell Research. 21(10). 1393–1409. 72 indexed citations

15.

Meinhold‐Heerlein, Ivo, Dirk Bauerschlag, Yingyao Zhou, et al.. (2007). An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma. Clinical Cancer Research. 13(2). 458–466. 41 indexed citations

16.

Heintzman, Nathaniel D., Rhona Stuart, Gary C. Hon, et al.. (2007). Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nature Genetics. 39(3). 311–318. 2463 indexed citations breakdown →

17.

Su, Andrew I., Tim Wiltshire, Serge Batalov, et al.. (2004). A gene atlas of the mouse and human protein-encoding transcriptomes. Proceedings of the National Academy of Sciences. 101(16). 6062–6067. 2820 indexed citations breakdown →

18.

Yang, Wen‐Chin, Keith A. Ching, Constantine D. Tsoukas, & Leslie J. Berg. (2001). Tec Kinase Signaling in T Cells Is Regulated by Phosphatidylinositol 3-Kinase and the Tec Pleckstrin Homology Domain. The Journal of Immunology. 166(1). 387–395. 59 indexed citations

19.

Ching, Keith A., Yuko Kawakami, Toshiaki Kawakami, & Constantine D. Tsoukas. (1999). Emt/Itk Associates with Activated TCR Complexes: Role of the Pleckstrin Homology Domain. The Journal of Immunology. 163(11). 6006–6013. 52 indexed citations

20.

Stoppler, Melissa C., Keith A. Ching, Hubert Stöppler, et al.. (1996). Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. Journal of Virology. 70(10). 6987–6993. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact